West Branch Capital LLC Eli Lilly & CO Transaction History

West Branch Capital LLC

$274 Million
Q3 2024

A detailed history of West Branch Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, West Branch Capital LLC holds 4,512 shares of LLY stock, worth $3.38 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares

4,512

Previous 4,330 4.2%

Holding current value

$3.38 Million

Previous $3.92 Million 1.96%

% of portfolio

1.46%

Previous 1.53%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $140,529 - $174,723	182 Added 4.2%	4,512 $4 Million
Q2 2024 Jul 26, 2024	BUY	$724.87 - $909.04 $76,111 - $95,449	105 Added 2.49%	4,330 $3.92 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $374,270 - $500,720	632 Added 17.59%	4,225 $3.29 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $258,393 - $304,611	492 Added 15.87%	3,593 $2.09 Million
Q3 2023 Oct 20, 2023	BUY	$434.7 - $599.3 $19,996 - $27,567	46 Added 1.51%	3,101 $1.67 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $65,237 - $87,230	186 Added 6.48%	3,055 $1.43 Million
Q1 2023 Apr 20, 2023	SELL	$310.63 - $364.82 $6,523 - $7,661	-21 Reduced 0.73%	2,869 $985,000
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $321 - $374	1 Added 0.03%	2,890 $0
Q3 2022 Oct 19, 2022	BUY	$296.48 - $337.87 $13,341 - $15,204	45 Added 1.58%	2,889 $934,000
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $278 - $327	-1 Reduced 0.04%	2,844 $922,000
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $49,988 - $62,123	-213 Reduced 6.97%	2,845 $815,000
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $123,217 - $152,913	548 Added 21.83%	3,058 $845,000
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $41,660 - $51,269	188 Added 8.1%	2,510 $580,000
Q2 2021 Aug 17, 2021	BUY	$180.55 - $233.54 $150,217 - $194,305	832 Added 55.84%	2,322 $532,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $244,836 - $316,952	1,490 New	1,490 $278,000
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $578,851 - $765,959	-4,437 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $48,691 - $56,320	333 Added 8.11%	4,437 $657,000
Q2 2020 Jul 08, 2020	BUY	$136.42 - $164.18 $559,867 - $673,794	4,104 New	4,104 $674,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.

Account

West Branch Capital LLC Eli Lilly & CO Transaction History